TB-500 for Dogs: What the Research Says
TB-500 (a thymosin β4 fragment) has the longest track record of any recovery peptide in animals. Here's what it's studied for in dogs, how it differs from BPC-157, and the safety reality.
What is TB-500 and how does it work?
TB-500 is a synthetic fragment of thymosin β4 — a naturally occurring peptide found in almost all animal cells, including your dog's. It isn't an exotic drug so much as a lab-made version of a signal the body already uses when it's healing.
Its mechanism is what makes it interesting. Thymosin β4 binds actin, a core structural protein inside cells, and helps repair cells mobilize and migrate to injury sites. It also supports new blood-vessel formation and reduces inflammation. Because it works by moving repair cells around the body rather than acting only at one spot, TB-500 is described as more systemic, where BPC-157 is described as more local.
What is TB-500 studied for in dogs?
In animals, thymosin β4 and its TB-500 fragment have been studied for tendon and ligament recovery, wound healing, and broad soft-tissue regeneration. The wound-healing research is notable: in animal models, thymosin β4 has been reported to speed re-epithelialization (the skin closing over a wound) meaningfully compared with untreated controls.
For dogs, the interest concentrates on soft-tissue and tendon recovery — especially in active, working, or sporting dogs, and in recovery after a strain or surgery. As with BPC-157, most controlled data is pre-clinical, so 'studied for' is the accurate framing, not 'proven to treat.'
Why is TB-500 associated with horses?
TB-500 has the longest real-world track record of any of these peptides, and it comes from equine sports medicine, where it's been used for tendon and ligament injuries for years. That history is a big part of why dog owners — especially of athletic breeds — ask about it.
It's worth being precise, though: a long practical history in horses is real-world experience, not the same as controlled, published canine trials. It's a reason to take TB-500 seriously and a reason to keep the vet in the loop, not a substitute for one.
How is TB-500 different from BPC-157?
- Mode: BPC-157 acts more locally at the injury; TB-500 works more systemically via cell migration.
- Signature research: BPC-157 = gut lining + local repair; TB-500 = broad soft-tissue + wound healing.
- Track record: BPC-157 = most-discussed pet peptide; TB-500 = longest history in horses.
- Form: BPC-157 is used orally or injected; TB-500 is typically injected.
- They're often paired — which is why the BPC-157 + TB-500 stack and the KLOW blend exist.
- Both are research-use compounds; neither is FDA-approved for pets.
How is TB-500 given, and is it safe for dogs?
TB-500 is typically studied as a subcutaneous injection. This guide doesn't publish dosing, because a safe amount depends on your individual dog's weight, health, and goal — that's a veterinary decision, not a chart.
On safety: animal studies of thymosin β4 have shown strong tissue-repair effects and generally good tolerability, and the long equine use history is reassuring. But there's no FDA approval for pets, no standardized dog-specific dosing, and limited long-term companion-animal safety data. Product quality also varies between sellers, so a third-party-tested source with a Certificate of Analysis is the minimum bar, and the decision belongs with your vet.
Bottom line
TB-500 is the veteran of the recovery peptides — the strongest real-world track record (in horses), a well-described repair mechanism, and encouraging animal wound-healing data. It's also, like the others, an early-stage, research-grade compound for dogs specifically. Bring your dog's actual injury or goal to your vet, and let that conversation — not a product page — decide whether TB-500, BPC-157, a combination, or neither makes sense.
Frequently asked questions
Is TB-500 the same as thymosin beta-4?
TB-500 is a synthetic fragment based on thymosin β4. They're closely related and often discussed interchangeably, but TB-500 refers to the lab-made fragment sold for research.
Should I give TB-500 or BPC-157 for my dog's recovery?
They're studied for overlapping but different roles — TB-500 leans systemic, BPC-157 leans local. Which (if either) fits your dog is a veterinary decision based on the specific injury and goal.
Is TB-500 used in horses?
Yes — TB-500 has the longest practical track record in equine sports medicine for tendon and ligament injuries, which is part of why it's studied in dogs too.
How is TB-500 given to dogs?
It's typically studied as a subcutaneous injection. The form, amount, and schedule should be set by your veterinarian; there's no approved standard dose for pets.
Is TB-500 safe for dogs?
Animal research shows generally good tolerability, but there's no FDA approval, no standardized canine dosing, and limited long-term data. Use a tested product and involve your vet.
Can TB-500 be used for cats?
There's far less data in cats, and cats metabolize substances differently than dogs, so extra caution is warranted. Any feline use should be under direct veterinary supervision.
Research references
We cite primary research so you can read it yourself. These are studies about the compounds discussed — most are pre-clinical or in other species, and none establish approved dosing for pets. Read them as context for a vet conversation, not instructions.
Not veterinary advice. The peptides discussed are research-grade compounds, not FDA-approved for pets. Always consult a licensed veterinarian before giving anything to your animal.